Clinical Trials Browser

Terminated × Lymphoma, B-Cell × Tacrolimus × Clear all

NCT00946023 2018-08-27

Optimized Donor Selection, Nonmyeloablative BMT for B-cell Lymphomas With Post-transplantation Cy and Rituximab

Phase 2 Terminated

135 enrolled 17 charts

LymphoidOther hematologic neoplasm

Lymphoma, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell